These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 15819586)

  • 21. Combination therapy with clopidogrel and aspirin after coronary stenting.
    Kolansky DM; Klugherz BD; Curran SC; Herrmann HC; Magness K; Wilensky RL; Hirshfeld JW
    Catheter Cardiovasc Interv; 2000 Jul; 50(3):276-9. PubMed ID: 10878621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
    Jura-Szołtys E; Chudek J
    Kardiol Pol; 2011; 69(8):817-23. PubMed ID: 21850627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Late coronary stent thrombosis and clopidogrel].
    Varvarovský I; Matejka J; Herman A
    Vnitr Lek; 2007 Oct; 53(10):1085-91. PubMed ID: 18072434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.
    Sharma RK; Reddy HK; Singh VN; Sharma R; Voelker DJ; Bhatt G
    Vasc Health Risk Manag; 2009; 5():965-72. PubMed ID: 19997577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.
    Thukkani AK; Agrawal K; Prince L; Smoot KJ; Dufour AB; Cho K; Gagnon DR; Sokolovskaya G; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
    J Am Coll Cardiol; 2015 Sep; 66(10):1091-101. PubMed ID: 26337986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy.
    Stone GW; Aronow HD
    Mayo Clin Proc; 2006 May; 81(5):641-52. PubMed ID: 16706262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature.
    Carlsson J; von Wagenheim B; Linder R; Anwari TM; Qvist J; Petersson I; Magounakis T; Lagerqvist B
    Clin Res Cardiol; 2007 Feb; 96(2):86-93. PubMed ID: 17180577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention.
    Sardella G; Bucciarelli-Ducci C; Mancone M; Colantonio R; Sangiorgi GM; Fedele F
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):625-8. PubMed ID: 17667035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S; Berger P
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.
    Fiedler KA; Byrne RA; Schulz S; Sibbing D; Mehilli J; Ibrahim T; Maeng M; Laugwitz KL; Kastrati A; Sarafoff N
    Am Heart J; 2014 Apr; 167(4):459-465.e1. PubMed ID: 24655693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).
    Waksman R; Ajani AE; White RL; Pinnow E; Dieble R; Bui AB; Taaffe M; Gruberg L; Mintz GS; Satler LF; Pichard AD; Kent KK; Lindsay J
    Circulation; 2001 May; 103(19):2332-5. PubMed ID: 11352879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?].
    Baer FM; Erdmann E
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1275-80. PubMed ID: 17541871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.
    Mishkel GJ; Aguirre FV; Ligon RW; Rocha-Singh KJ; Lucore CL
    J Am Coll Cardiol; 1999 Dec; 34(7):1884-90. PubMed ID: 10588198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clopidogrel treatment surrounding percutaneous coronary intervention: when should it be started and stopped?
    Coolong A; Mauri L
    Curr Cardiol Rep; 2006 Jul; 8(4):267-71. PubMed ID: 16822362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
    Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
    J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.